Vanguard Group Inc Acer Therapeutics Inc. Transaction History

Vanguard Group Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.57 - $1.28 $33,646 - $75,557	59,029 Added 14.22%	474,094 $388,000
Q1 2023 May 15, 2023	BUY	$0.67 - $3.05 $51,382 - $233,907	76,691 Added 22.66%	415,065 $315,000
Q4 2022 Feb 10, 2023	BUY	$1.13 - $4.15 $67,506 - $247,921	59,740 Added 21.44%	338,374 $849,000
Q3 2022 Nov 14, 2022	SELL	$1.28 - $1.6 $2,284 - $2,856	-1,785 Reduced 0.64%	278,634 $387,000
Q2 2022 Aug 12, 2022	BUY	$1.19 - $3.04 $2,622 - $6,700	2,204 Added 0.79%	280,419 $353,000
Q1 2022 May 13, 2022	BUY	$1.98 - $2.98 $196,683 - $296,018	99,335 Added 55.53%	278,215 $807,000
Q4 2021 Feb 14, 2022	SELL	$1.88 - $2.9 $5,376 - $8,294	-2,860 Reduced 1.57%	178,880 $408,000
Q3 2021 Nov 12, 2021	BUY	$2.3 - $2.86 $5,973 - $7,427	2,597 Added 1.45%	181,740 $465,000
Q2 2021 Aug 13, 2021	BUY	$2.52 - $3.18 $451,440 - $569,674	179,143 New	179,143 $512,000

365

Ticker ACER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,100,000
Description
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.